Brian G. Lloyd - 04 Mar 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Brian G. Lloyd
Issuer symbol
MMSI
Transactions as of
04 Mar 2025
Transactions value $
-$1,415,100
Form type
4
Date filed
06 Mar 2025, 17:38
Previous filing
03 Mar 2025
Next filing
14 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Gift $0 -48 -0.12% $0.00 38.9K 04 Mar 2025 Direct
transaction MMSI Common Stock, No Par Value Options Exercise $1.67M +30K +77.03% $55.73 68.9K 05 Mar 2025 Direct
transaction MMSI Common Stock, No Par Value Sale -$3.09M -30K -43.51% $102.90 38.9K 05 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -30K -100% $0.00 0 05 Mar 2025 Common Stock 30K $55.73 Direct F2
holding MMSI Non-qualified stock options (right to buy) 16.7K 04 Mar 2025 Common Stock 16.7K $37.71 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9.68K 04 Mar 2025 Common Stock 9.68K $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 8.09K 04 Mar 2025 Common Stock 8.09K $65.03 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13.6K 04 Mar 2025 Common Stock 13.6K $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.92 to $103.36, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
F3 Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
F4 Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F6 Become exercisable in equal annual installments of 25% commencing on 02/28/2024.